The way I see it, there is really no hurry with the FDA approval. Look at how much there is to do just in Australia and UK now. We have recently gone past breakeven point in Australia. I believe their current objective now is to go pass breakeven point in UK. Once both these countries are profitable, they would then have the fund to tackle the US market and any other oncoming markets. Slow and steady wins the race.
PainChek General Discussion, page-2512
-
- There are more pages in this discussion • 17,901 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
